FDA DrugClass IINotable

FDA Recall: NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella

Date: 2026-05-13

Brand: Acella Pharmaceuticals, LLC

Category: Drug

FDA Class: Class II

Description

Chemical contamination; presence of lead and lithium above specification

Hazard

Chemical contamination; presence of lead and lithium above specification

Remedy

6,336 bottles

View original recall →

Share:

Related Recalls

2026-08-12 · FDA_DRUG

FDA Recall: Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesci

Zydus Pharmaceuticals (USA) Inc

2026-08-12 · FDA_DRUG

FDA Recall: Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pha

Aurobindo Pharma USA Inc

2026-08-12 · FDA_DRUG

FDA Recall: Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: L

Sunny Pharmtech Inc.

2026-08-12 · FDA_DRUG

FDA Recall: Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: L

Sunny Pharmtech Inc.